Effectiveness and impact of a 2-component acellular pertussis vaccine as a preschool booster in Finland – A register-based study (PER000108)

Study identification

• EU PAS number:
  EUPAS1000000107
• Study ID:
  1000000107
• Official title and acronym:
  Effectiveness and impact of a 2-component acellular pertussis vaccine as a preschool booster in Finland – A register-based study (PER000108)
• DARWIN EU® study:
  No
• Study countries:
  Finland
• Study description:
  This is a nationwide population-based register study on pertussis in children less than 14 years of age in 1995-2019. We will estimate the effectiveness of preschool pertussis vaccination in a cohort design, by previos vaccination status and by time since vaccination, and assess its impact by comparing vaccination programs with and without preschool vaccination. In addition, we will assess the patterns of pertussis by age, time, area, vaccination status and hospitalization.
• Study status:
  Ongoing

Research institutions and networks

Institutions

FVR – Finnish Vaccine Research

Finland

Study timelines

Date when funding contract was signed

Actual: 26/04/2023

Study start date

Actual: 03/07/2023

Data analysis start date

Planned: 30/06/2024

Date of final study report

Planned: 30/06/2025

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Sanofi Pasteur S.A.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable